Byron Bloom
Medical · Shelbyville, TNNPI 1801074042
Payments from drug & device makers
Across 157 payments — averaging $19.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$724
- Lilly USA, LLC$355
- AstraZeneca$271
- Axsome Therapeutics, Inc.$180
- Amgen$168
- Boehringer Ingelheim$142
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,089100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 35 | $724 |
| Lilly USA, LLC | 23 | $355 |
| AstraZeneca | 17 | $271 |
| Axsome Therapeutics, Inc. | 2 | $180 |
| Amgen | 9 | $168 |
| Boehringer Ingelheim | 8 | $142 |
| Boston Scientific | 2 | $134 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $125 |
| Novo Nordisk | 7 | $122 |
| Exact Sciences | 6 | $100 |
| Pfizer | 6 | $100 |
| Johnson & Johnson | 5 | $97 |
| Xeris Pharmaceuticals, Inc. | 4 | $82 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| Bayer | 4 | $72 |
| Amarin Pharma, Inc. | 2 | $46 |
| Neurelis, Inc. | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Lundbeck LLC | 2 | $35 |
| Redhill Biopharma Inc. | 2 | $34 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $27 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Medtronic | 1 | $16 |
| Novartis | 1 | $16 |
| Advanced Oxygen Therapy Inc. | 1 | $13 |
| GSK | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$104
How this compares
$3,089 in reported general payments places this provider in the 80th percentile of 480 medical providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 148 | $166,471 |
| JardianceEmpagliflozin | 94 | $84,623 |
| FarxigaDapagliflozin Propanediol | 107 | $81,087 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 84 | $68,823 |
| MounjaroTirzepatide | 63 | $68,580 |
| Xigduo XrDapaglifloz Propaned/Metformin | 74 | $55,072 |
| RybelsusSemaglutide | 32 | $44,764 |
| XareltoRivaroxaban | 37 | $38,322 |
| SynjardyEmpagliflozin/Metformin Hcl | 34 | $32,582 |
| TradjentaLinagliptin | 28 | $31,629 |
| Tresiba Flextouch U-100Insulin Degludec | 32 | $25,512 |
| LinzessLinaclotide | 38 | $21,104 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 26 | $20,031 |
| VraylarCariprazine Hcl | 13 | $19,776 |
| EntrestoSacubitril/Valsartan | 18 | $19,637 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Synjardy Xr, Synjardy, Tradjenta | $142 | $217,656240 claims |
| Novo NordiskOzempic, Rybelsus | $122 | $211,235180 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $271 | $107,834149 claims |
| Lilly USA, LLCMounjaro, Trulicity | $355 | $84,63079 claims |
| AbbVieLinzess, Vraylar | $724 | $40,88051 claims |
| Johnson & JohnsonXarelto | $97 | $38,32237 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $12 | $31,95239 claims |
| NovartisEntresto | $16 | $19,63718 claims |
| PfizerEliquis | $100 | $19,06321 claims |
| Axsome Therapeutics, Inc.Auvelity | $180 | $13,35112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 480 medical providers in Tennessee.
Other medical in Shelbyville
- Maria WoodChattanooga$130K
- Alyssa JamesonFranklin$65K
- Melissa LambertHendersonville$47K
- Stephanie HowardKnoxville$18K
- Evan HatfillNashville$18K
- Meredith McDanielChattanooga$17K
- Janet BreedingKnoxville$15K
- Paul MabenKnoxville$13K
- Hannah KirkGreeneville$13K
- Scarlett FordNashville$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.